fbpx

Year

2012
The Grete Lundbeck European Brain Research Foundation announced today that The Brain Prize 2012 is jointly awarded to Christine Petit and Karen Steel:
  Viaskin Peanut, the first epicutaneous skin patch for the treatment of peanut allergy, is recognized as a unique and promising desensitization product   BAGNEUX, France, February 28, 2012 – DBV Technologies announced today that it has received Fast Track Designation” for the Clinical Development Program of its Viaskin® Peanut, a product designed for the...
  LA JOLLA, Calif., Feb. 15, 2012 /PRNewswire/ — Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it has completed a $43 million equity financing to advance its lead investigational product candidate MYDICAR® for the treatment of heart failure. The financing was led...
The Lundbeck Foundation is expanding its activities and establishing start up financing for selected new Danish life science projects. We are seeking a partner with industrial and operational experience combined with solid academic background to be a partner in this program.
Light is life-giving. Emission of absorbed light, or fluorescence, has given life to young scientist's career. The Lundbeck Foundation has awarded the 30-year-old post.doc. Thomas Just Sørensen, Keble College, Oxford University and Department of Chemistry, University of Copenhagen the Talent Prize for younger scientists. The prize is a personal award of 100.000 DKK (approx. £11.000).
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in the STRATO (Switching kidney TRAnsplant patients with Tremor to LCP-tacrO) Phase IIIb study of LCP-TacroT in kidney transplant recipients experiencing drug-induced tremors. The STRATO study is designed to explore whether a conversion of patients who have symptomatic tremor from treatment with standard...
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for cancer supportive care, announces the initiation of a Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV). PONV remains a clinically significant problem in patients undergoing major surgery, despite the availability of a range of anti-emetic medications. APD421...
1 2 3 4 5

News

Maude has become the stereotypical migraine patient – but it’s not quite the true picture
31. July 2020
Ancient DNA throws a ‘scientific hand grenade’ into the discussion about the arrival of humans in North America
23. July 2020
Danish researchers map key disease mechanism – and describe a completely new protein
20. July 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge